HighTower Advisors, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1462245 CHICAGO, IL

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$6,748,898

+$1,105,381 QoQ

Shares Held

224,067

+23.9% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Dec 31, 2023

CallValue

CallShares

PutValue

$73,080

PutShares

7,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

HighTower Advisors, LLC holds $76,791,783 across 32 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	419,904	$49,636,851
2	TEVA	Teva Pharmaceutical Industries Ltd This page	224,067	$6,748,898
3	UTHR	UNITED THERAPEUTICS Corp	4,894	$2,902,044
4	HLN	Haleon plc	192,177	$1,923,691
5	TAK	Takeda Pharmaceutical Co Ltd	103,082	$1,909,078
6	NBIX	Neurocrine Biosciences Inc	11,198	$1,475,224
7	VTRS	Viatris Inc	108,052	$1,459,782
8	AMRX	Amneal Pharmaceuticals, Inc.	93,386	$1,160,787

All Filings in TEVA

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,748,898	224,067	+23.9%	Shares	Sole	2026-05-05
2025-12-31	$5,643,517	180,824	+4.6%	Shares	Sole	2026-02-06
2025-09-30	$3,490,600	172,802	+167.9%	Shares	Sole	2025-11-07
2025-06-30	$1,080,869	64,491	-64.9%	Shares	Sole	2025-08-11
2025-03-31	$2,820,932	183,535	-6.7%	Shares	Sole	2025-05-13
2024-12-31	$4,334,320	196,657	+32.3%	Shares	Sole	2025-02-07
2024-09-30	$2,677,862	148,605	+461.8%	Shares	Sole	2024-11-14
2024-06-30	$429,828	26,451	-3.3%	Shares	Sole	2024-08-13
2024-03-31	$385,964	27,354	+290.8%	Shares	Sole	2024-05-06
2023-12-31	$73,080	7,000	-74.3%	Put	Sole	2024-02-12
2023-12-31	$284,448	27,246	-16.4%	Shares	Sole	2024-02-12
2023-09-30	$332,418	32,590	+12936.0%	Shares	Sole	2023-11-08
2023-06-30	$1,882	250	-99.2%	Put	Sole	2023-08-14
2023-06-30	$242,202	32,165	-82.4%	Shares	Sole	2023-08-14
2023-03-31	$1,619,541	182,999	+916.7%	Shares	Sole	2023-05-12
2023-03-31	$159,300	18,000	-93.9%	Call	Sole	2023-05-12
2022-12-31	$2,675,926	293,413	-5.7%	Shares	Sole	2023-02-09
2022-09-30	$2,509,882	311,014	-19.5%	Shares	Sole	2022-11-09
2022-06-30	$2,903,705	386,131	+1578.8%	Shares	Sole	2022-08-10
2022-06-30	$172,960	23,000	-93.0%	Call	Sole	2022-08-10
2022-03-31	$3,084,276	328,464	+93746.9%	Shares	Sole	2022-05-12
2022-03-31	$3,286	350	-99.8%	Call	Sole	2022-05-12
2021-12-31	$1,832,103	228,727	+57081.8%	Shares	Sole	2022-02-10
2021-12-31	$3,204	400	-99.8%	Put	Sole	2022-02-10
2021-09-30	$2,496,137	256,277	+24.4%	Shares	Sole	2021-11-12
2021-09-30	$2,006,440	206,000	+58.5%	Put	Sole	2021-11-12
2021-06-30	$1,287,000	130,000	+133.7%	Call	Sole	2021-08-06
2021-06-30	$550,806	55,637	+2.6%	Shares	Sole	2021-08-06
2021-03-31	$625,618	54,213	+3886.2%	Shares	Sole	2021-05-10
2021-03-31	$15,694	1,360	-97.2%	Put	Sole	2021-05-10
2020-12-31	$464,908	48,177	+48077.0%	Shares	Sole	2021-02-10
2020-12-31	$965	100	-90.0%	Put	Sole	2021-02-10
2020-12-31	$9,650	1,000	-97.1%	Call	Sole	2021-02-10
2020-09-30	$315,485	35,015	+112.2%	Shares	Sole	2020-11-13
2020-09-30	$148,665	16,500	+1550.0%	Call	Sole	2020-11-13
2020-06-30	$12,330	1,000	-97.2%	Call	Sole	2020-08-10
2020-06-30	$433,831	35,185	+1.9%	Shares	Sole	2020-08-10
2020-03-31	$310,124	34,535	—	Shares	Sole	2020-05-21
No filing history on record for this holder in this stock.